Figure 2. Cumulative incidence of inhibitor development according to treatment regimen: prophylaxis versus on demand.
Figure 2

Cumulative incidence of inhibitor development according to treatment regimen: prophylaxis versus on demand.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal